Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice

Pharmacology Biochemistry and Behavior

Volumn 92, Issue 1, 2009, Pages 82-87

  Mutlu, Oguz ^a,b   Ulak, Güner ^b   Laugeray, Anthony ^a   Belzung, Catherine ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b KOCAELI UNIVERSITY   (Turkey)

Author keywords

Antidepressant; Mice; Nitric oxide; TRIM; Unpredictable chronic mild stress

Indexed keywords

1 [2 (TRIFLUOROMETHYL) PHENYL]IMIDAZOLE; FLUOXETINE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GROOMING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRESS;

AGGRESSION; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; CHRONIC DISEASE; DEPRESSIVE DISORDER; ENZYME INHIBITORS; FLUOXETINE; GROOMING; HAIR; IMIDAZOLES; MALE; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; NITRIC OXIDE SYNTHASE TYPE I; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL;

ANIMALIA; MUS;

EID: 58549101276     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.10.013     Document Type: Article

References (54)

1. Arbe M.D., Einstein R., and Lavidis N.A. Stressful animal housing conditions and their potential effect on sympathetic neurotransmission in mice. Am J Physiol Regul Integr Comp Physiol 282 (2002) 1422-1428
2. Baranano D.E., Ferris C.D., and Snyder S.H. A typical neural messengers. Trends Neurosci 24 (2001) 99-106
3. Boissier J.R., and Simon P. Action de la caffeine sur la motilite' spontanne'e chez la souris. Arch Int Pharmacodyn 158 (1965) 212-221
4. Da Silva G.D., Matteussi A.S., dos Santos A.R., Calixto J.B., and Rodrigues A.L. Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice. Neurorep 11 (2000) 3699-3702
5. De Oliveira R.M., Del Bel E.A., Mamede-Rosa M.L., Padovan C.M., Deakin J.F., and Guimarães F.S. Expression of neuronal nitric oxide synthase mRNA in stress-related brain areas after restraint in rats. Neurosci Lett 289 (2000) 123-126
6. De Oliveira R.M.W., Guimarães F.S., and Deakin J.F.W. Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders. Braz J Med Biol Res 41 4 (2008) 333-341
7. Ducottet C., and Belzung C. Behaviour in the elevated plus-maze predicts coping after subchronic mild stress in mice. Physiol Behav 81 (2004) 417-426
8. Ducottet C., Griebel G., and Belzung C. Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 27 (2003) 625-631
9. Dzoljic E., De Vries R., and Dzoljic M.R. New and potent inhibitors of nitric oxide synthase reduce motor activity in mice. Behav Brain Res 87 (1997) 209-212
10. Eckeli A.L., Dach F., and Rodrigues A.L.S. Acute treatments with GMP produce antidepressant-like effects in mice. NeuroRep 11 (2000) 1839-1843
11. Escott K.J., Beech J.S., Haga K.K., Williams S.C., Meldrum B.S., and Bath P.M. Cerebroprotective effect of the nitric oxide synthase inhibitors, 1-(2-trifluoromethyl-phenyl) imidazole and 7-nitro indazole, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 18 (1998) 281-287
12. Fidecka S. Study on the influence of potent inhibitors of neuronal nitric oxide synthase on the antinociceptive and anticonvulsant activity of benzodiazepines in mice. Pol J Pharmacol 55 (2003) 193-201
13. Finkel M.S., Laghrissi-Thode F., Pollock B.G., and Rong J. Paroxetine is a novel nitric oxide synthase inhibitor. Psychopharmacol Bull 32 4 (1996) 653-658
14. Ghasemi M., Sadeghipour H., Mosleh A., Sadeghipour H.R., Mani A.R., and Dehpour A.R. Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test. Eur Neuropsychopharmacol 18 (2008) 323-332
15. Haleem D.J., and Parveen T. Brain regional serotonin synthesis following adaptation to repeated restraint. NeuroRep 5 (1994) 1785-1788
16. Handy R.L., Harb H.L., Wallace P., Gaffen Z., Whitehead K.J., and Moore P.K. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects. Br J Pharmacol 119 2 (1996) 423-431
17. Handy R.L.C., and Moore P.K. Mechanism of the inhibition of neuronal nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM). Life Sci 60 (1997) 389-394
18. Handy R.L.C., Wallace P., Gaffen Z.A., Whitehead K.J., and Moore P.K. The antinociceptive effect of 1-(2-trifluoromethylphenyl)imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. Br J Pharmacol 116 (1995) 2349-2350
19. Harkin A., Bruce K.H., Craft B., and Paul I.A. Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Eur J Pharmacol 372 (1999) 207-213
20. Harkin A., Connor T.J., Burns M.P., and Kelly J.P. Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. Eur Neuropsychopharmacol 14 4 (2004) 274-281
21. Harvey B.H., Oosthuizen F., Brand L., Wegener G., and Stein D.J. Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus. J Psychopharmacol 175 (2004) 494-502
22. Holscher C. Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity. Trends Neurosci 20 (1997) 298-303
23. Jefferys D., and Funder J. Nitric oxide modulates retention of immobility in the forced swimming test in rats. Eur J Pharmacol 295 (1996) 131-135
24. Jopek R., Kata M., and Nowak G. The activity of rat brain nitric oxide synthase following chronic antidepressant treatment. Acta Pol Pharm 56 4 (1999) 307-310
25. Kiecolt-Glaser J., and Glaser R. Depression and immune function. Central pathways to morbidity and mortality. J Psychosom Res 53 (2002) 873
26. Kiss J.P. Role of nitric oxide in the regulation of monoaminergic neurotransmission. Brain Res Bull 52 (2000) 459-466
27. Li J.M., Kong L.D., Wang Y.M., Cheng C.H.K., Zhang W.Y., and Tan W.Z. Behavioral and biochemical studies on chronic mild stress models in rats treated with a Chinese traditional prescription Banxia-houpu decoction. Life Sci 74 (2003) 55-73
28. Lipton S.A. Neuronal protection and destruction by NO. Cell Death Differ 6 (1999) 943-951
29. Michard C., and Carlier M. Les conduites d'agression intraspécifique chez la souris domestique: Différences individuelles et analyses génétiques. Biol Behav 10 (1985) 123-146
30. Mineur Y.S., Prasol D.J., Belzung C., and Crusio W.E. Agonistic behavior and unpredictable chronic mild stress in mice. Behav Gen 33 5 (2003) 513-519
31. Muscat R., and Willner P. Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis. Neurosci Biobehav Rev 16 (1992) 507-517
32. Nelson R.J., and Chiavegatto S. Molecular basis of aggression. Trends Neurosci 24 (2001) 713-719
33. Nelson R.J., Demas G.E., Huang P.L., Fishman M.C., Dawson V.L., Dawson T.M., et al. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 378 (1995) 383-386
34. Rogóz Z., Skuza G., Maj J., and Danysz W. Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats. Neuropharmacology 42 (2002) 1024-1030
35. Sanchez M.M., Aguado F., Sanchez-Toscano F., and Saphier D. Neuroendocrine and immunocytochemical demonstrations of decreased hypothalamo-pituitary-adrenal axis responsiveness to restraint stress after long-term social isolation. Endocrinology 139 (1998) 579-587
36. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., and Dulawa S. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
37. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57 (2000) 925-935
38. Schuman E.M., and Madison D.V. Nitric oxide and synaptic function. Annu Rev Neurosci 17 (1994) 153-183
39. Smith J.C.E., and Whitton P.S. Nitric oxide modulates N-methyl-d-aspartate-evoked serotonin release in the raphe nuclei and frontal cortex of the freely moving rat. Neurosci Lett 291 (2000) 5-8
40. Spani D., Arras M., Konig B., and Rulicke T. Higher heart rate of laboratory mice housed individually vs in pairs. Lab Anim 37 (2003) 54-62
41. Surget A., Saxe M., Leman S., Ibarguen-Vargas Y., Chalon S., Griebel G., et al. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol Psychiat 64 4 (2008) 293-301
42. Tannenbaum B., and Anisman H. Impact of chronic intermittent challenges in stressor-susceptible and resilient strains of mice. Biol Psychiatry 53 (2003) 292-303
43. Vancassel S., Leman S., Hanonick L., Denis S., Roger J., Nollet M., et al. n-3 polyunsaturated fatty acid supplementation reverses stress-induced modifications on brain monoamine levels in mice. J Lipid Res 49 2 (2008) 340-348
44. Volke V., Wegener G., Bourin M., and Vasar E. Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. Behav Brain Res 140 (2003) 141-147
45. Wegener G., Volke V., and Rosenberg R. Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. Br J Pharmacol 130 (2000) 575-580
46. Wegener G., Volke V., Harvey B.H., and Rosenberg R. Local, but not systemic administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity. Brain Res 959 (2003) 128-134
47. Wiley J.L., Cristello A.F., and Balster R.L. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice. Eur J Pharmacol 294 (1995) 101-107
48. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 134 (1997) 319-329
49. Willner P., Muscat R., and Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16 (1992) 525-534
50. Yalçi{dotless}n I., Aksu F., and Belzung C. Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol. Eur J Pharmacol 514 (2005) 165-174
51. Yalçi{dotless}n I., Coubard S., Bodard S., Chalon S., and Belzung C. Effects of 5,7-dihydroxytrptamine lesion of the dorsal raphe nucleus on the antidepressant-like action of tramadol in the unpredictable chronic mild stress in mice. Psychopharmacology(Berl) 200 4 (2008) 497-507
52. Yildiz F., Erden B.F., Ulak G., Utkan T., and Gacar N. Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology (Berl) 149 (2000) 41-44
53. Yildiz F., Ulak G., Erden B.F., and Gacar N. Anxiolytic-like effects of 7-nitroindazole in the rat plus-maze test. Pharmacol Biochem Behav 65 (2000) 199-202
54. Zhou Q., Hu Y., Hua Y., Mei H., Luo C., and Han X. Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis. J Neurochem 103 5 (2007) 1843-1854